These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19331135)

  • 1. Changes in plasma TIMP-1 levels after resection for primary colorectal cancer.
    Frederiksen C; Lomholt AF; Davis GJ; Dowell BL; Blankenstein MA; Christensen IJ; Brünner N; Nielsen HJ
    Anticancer Res; 2009 Jan; 29(1):75-81. PubMed ID: 19331135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer.
    Holten-Andersen MN; Nielsen HJ; Sørensen S; Jensen V; Brünner N; Christensen IJ
    Eur J Cancer; 2006 Aug; 42(12):1889-96. PubMed ID: 16809030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.
    Holten-Andersen MN; Stephens RW; Nielsen HJ; Murphy G; Christensen IJ; Stetler-Stevenson W; Brünner N
    Clin Cancer Res; 2000 Nov; 6(11):4292-9. PubMed ID: 11106246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
    Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
    Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of elective resection on plasma TIMP-1 levels in patients with colon cancer.
    Hammer JH; Basse L; Svendsen MN; Werther K; Brünner N; Christensen IJ; Nielson HJ
    Colorectal Dis; 2006 Mar; 8(3):168-72. PubMed ID: 16466554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: a prospective validation study.
    Birgisson H; Nielsen HJ; Christensen IJ; Glimelius B; Brünner N
    Eur J Cancer; 2010 Dec; 46(18):3323-31. PubMed ID: 20619633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in soluble CEA and TIMP-1 levels during adjuvant chemotherapy for stage III colon cancer.
    Aldulaymi B; Christensen IJ; Sölétormos G; Jess P; Nielsen SE; Brünner N; Nielsen HJ
    Anticancer Res; 2010 Jan; 30(1):233-7. PubMed ID: 20150641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1.
    Nielsen HJ; Christensen IJ; Brünner N
    Scand J Gastroenterol; 2010; 45(2):200-7. PubMed ID: 20095885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentration of tissue inhibitor of matrix metalloproteinase 1 in patients with colorectal carcinoma.
    Yukawa N; Yoshikawa T; Akaike M; Sugimasa Y; Takemiya S; Yanoma S; Noguchi Y; Takanashi Y
    Br J Surg; 2001 Dec; 88(12):1596-601. PubMed ID: 11736971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer.
    Sørensen NM; Schrohl AS; Jensen V; Christensen IJ; Nielsen HJ; Brünner N
    Scand J Gastroenterol; 2008; 43(2):186-91. PubMed ID: 18224564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals.
    Nielsen HJ; Brünner N; Jorgensen LN; Olsen J; Rahr HB; Thygesen K; Hoyer U; Laurberg S; Stieber P; Blankenstein MA; Davis G; Dowell BL; Christensen IJ; ;
    Scand J Gastroenterol; 2011 Jan; 46(1):60-9. PubMed ID: 20799911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) in colorectal cancer patients.
    Ishida H; Murata N; Hayashi Y; Tada M; Hashimoto D
    Surg Today; 2003; 33(12):885-92. PubMed ID: 14669077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with colorectal cancer.
    Yukawa N; Yoshikawa T; Akaike M; Sugimasa Y; Takemiya S; Yanoma S; Imada T; Noguchi Y
    Anticancer Res; 2004; 24(3b):2101-5. PubMed ID: 15274408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue inhibitor of metalloproteinase-1 levels in plasma from tumour arteries and veins of patients with rectal cancer.
    Frederiksen C; Lykke J; Christensen IJ; Brünner N; Nielsen HJ
    Scand J Clin Lab Invest; 2007; 67(5):545-52. PubMed ID: 17763191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High plasma TIMP-1 and serum CEA levels during combination chemotherapy for metastatic colorectal cancer are significantly associated with poor outcome.
    Aldulaymi B; Byström P; Berglund A; Christensen IJ; Brünner N; Nielsen HJ; Glimelius B
    Oncology; 2010; 79(1-2):144-9. PubMed ID: 21150229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma gastrin, CEA, and CA 19-9 levels decrease after colorectal cancer resection.
    Bombski G; Gasiorowska A; Orszulak-Michalak D; Neneman B; Kotynia J; Strzelczyk J; Janiak A; Malecka-Panas E
    Int J Colorectal Dis; 2003 Mar; 18(2):148-52. PubMed ID: 12548418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer.
    Holten-Andersen MN; Murphy G; Nielsen HJ; Pedersen AN; Christensen IJ; Høyer-Hansen G; Brünner N; Stephens RW
    Br J Cancer; 1999 May; 80(3-4):495-503. PubMed ID: 10408859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomatic and Non-symptomatic Individuals.
    Christensen IJ; Brünner N; Dowell B; Davis G; Nielsen HJ; Newstead G; King D
    Anticancer Res; 2015 Sep; 35(9):4935-41. PubMed ID: 26254391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma TIMP-1 in patients with colorectal adenomas: a prospective study.
    Holten-Andersen MN; Fenger C; Nielsen HJ; Rasmussen AS; Christensen IJ; Brünner N; Kronborg O
    Eur J Cancer; 2004 Sep; 40(14):2159-64. PubMed ID: 15341992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.